← Open Payments lookup

STEFANIE SPENCE: Open Payments

NPI 1487046751 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$681 in 30 payments from 13 companies in 2025. Trend: 2023 $268 · 2024 $754 · 2025 $681

Food & beverage: $681
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.6$131
AKEBIA THERAPEUTICS INC4$109
Calliditas Therapeutics US Inc.3$86
AstraZeneca Pharmaceuticals LP4$77
Novartis Pharmaceuticals Corporation2$58
Bayer Healthcare Pharmaceuticals Inc.3$50
Novo Nordisk Inc2$48
Travere Therapeutics, Inc.1$27
SERVIER PHARMACEUTICALS LLC1$27
Merck Sharp & Dohme LLC1$21

Products named: JARDIANCE, TARPEYO, Auryxia, Fabhalta, Kerendia, Ozempic, IMFINZI, FARXIGA.

Industry payments across AL — which companies pay providers there.